Table 1.
Bioproject accession | Healthy Controls |
Patients with COVID-19 |
References | |||
---|---|---|---|---|---|---|
PBMCs | Platelet | BALF | PBMCs | Platelet | ||
PRJCA002326 | 3 | 0 | 4 | 3 | 0 | Xiong et al. (2020) |
PRJNA633393 | 6 | 0 | 0 | 7 | 0 | Wilk et al. (2020)a |
PRJNA634489 | 0 | 5 | 0 | 0 | 10 | Manne et al. (2020) |
PRJNA639275 | 34 | 0 | 0 | 32 | 0 | Arunachalam et al. (2020) |
PRJNA644579 | 0 | 0 | 0 | 39 | 0 | Kusnadi et al. (2021) |
PRJNA662985 | 0 | 0 | 0 | 37 | 0 | Zheng et al. (2020) |
The numbers of the samples are shown by the condition of the subject, healthy controls, or patients with COVID-19, and the source of the blood sample, BALF, PBMCs, or platelet. The number of included samples is 180 (48 healthy controls and 132 COVID-19).
These 13 datasets included single-cell RNA-Seq.
BALF, bronchoalveolar lavage fluid; PBMCs, peripheral blood mononuclear cells.